Stoke Therapeutics is based out of Bedford. Stoke Therapeutics, Inc. operates as a biotechnology company. The Company develops antisense oligonucleotide medicines and therapies that increase target gene expression to treat diseases caused by loss of protein function. Stoke Therapeutics serves patients and customers in the United States. The firm last filed a Form D notice of exempt offering of securities on 2018-11-02. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
Stoke Therapeutics, Inc.45 WIGGINS AVENUE
BEDFORD MA 01730
Business Phone: 781-430-8200
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS